Troy E. Wilson, Ph.D., J.D.
Board Member
Kura Oncology, Inc. (KURA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Troy E. Wilson, Ph.D., J.D.
Troy E. Wilson, Ph.D., J.D. is recorded as Board Member and CFO at Kura Oncology, Inc. (KURA). Kura Oncology, Inc. reported in an 8-K filed June 7, 2024 that Troy E. Wilson, Ph.D., J.D. was appointed Class I director, effective June 5, 2024.
“elected Troy E. Wilson, Ph.D., J.D. and Faheem Hasnain as Class I directors to hold office until our 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-05–present
-
Current
2022-02-07–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kura Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Troy Wilson CEO
- Jennifer Fulk CFO
- Kathleen Ford COO
- Thomas Doyle Chief Accounting Officer
- Carol A. Schafer Board Member
- Carol Schafer Board Member
- Diane Parks Board Member
- Faheem Hasnain Board Member
- Helen Collins, M.D. Board Member
- Mary T. Szela Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.